基于网络药理学探讨黄芪六君子汤治疗新冠肺炎恢复期的作用机制

doi:10.3976/j.issn.1002-4026.2020.05.002

Abstract

Abstract: We aimed to investigate the mechanism of Huangqi Liujunzi decoction in the treatment of COVID-19 based on Network Pharmacology.The chemical components and targets of Huangqi Liujunzi decoction were collected from the databases of TCMSP, Pubchem, and Swiss Target Prediction and standardized using the Uniprot database.COVID-19 related genes were obtained by the GeneCards database,and we further mapped the common genes of disease and drugs.The protein-protein interaction data were downloaded from the STRING database, and the components-key targets visual network graph and protein interaction network were constructed using Cytoscape software to screen out the core targets.The GO function and KEGG pathway enrichment were analyzed by R language algorithm, and the target-pathway network was constructed using Cytoscape software.The results showed that 145 compounds and 1618 corresponding targets were screened. The key active components included luteolin,kaempferol,nobiletin,naringenin,baicalein, and acacetin.The key targets included MAPK1/3/8/14,CASP3/8,IL6/1β,ALB,apoptosis regulatory protein,PTGS2,protooncogene, and protooncogene of REL.GO function enrichment analysis included 1421 biological processes, 63 molecular functions, and 36 cell components;KEGG pathway enrichment analysis revealed 41 pathways, including PI3K-Akt signaling pathway, apoptosis, endocrine resistance,MAPK signaling pathway,Toll-like receptor signaling pathway,and osteoclast differentiation.Huangqi Liujunzi Decoction has a therapeutic effect on COVID-19 through antiviral, anti-inflammatory, and immune regulation mechanisms.

Key words: Huangqi Liujunzi decoction, COVID-19, network pharmacology, antiviral, anti-inflammatory

CLC Number:

R285

WANG Zong-qing, NIE Hong-ke, LI Qing-xuan, WANG Xing-qiang, TANG Xiao-hu. Mechanism of Huangqi Liujunzi decoction in treating the recovery stage of COVID-19 based on network pharmacology[J].Shandong Science, 2020, 33(5): 14-26.

References 34

1	北京中医药学会肺系病专业委员会.新型冠状病毒肺炎恢复期中医药综合干预方案专家指导意见(草案)[J].北京中医药，2020，39（2）:102-104. doi: 10.16025/j.1674-1307.2020.02.002
2	国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案（试行第七版）的通知[EB/OL].(2020-03-03)[2020-03-05]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtm.
3	国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒感染的肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-23)[2020-04-21].http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2ffcbeel fa.shtml.
4	刘仕廉. 医学集成[M]. 北京: 中国中医药出版社, 2015.
5	塔娜, 张伟. 加味六君子汤治疗小儿过敏性咳嗽缓解期(肺脾气虚型)的临床观察[J]. 中医药信息, 2012, 29(2): 70-71. doi: 10.19656/j.cnki.1002-2406.2012.02.029
6	杨靖罡, 张庆天. 六君子汤加减方治疗老年肺部感染60例[J]. 医药导报, 2010, 29(4): 492-493. doi: 10.3870/yydb.2010.04.031
7	林水玉. 六君子汤治疗慢性阻塞性肺疾病稳定期肺脾气虚型患者的临床研究[D]. 福州: 福建中医药大学, 2013.
8	郝悦, 焦安妮, 于敏, 等. 30种黄酮抑制黄嘌呤氧化酶活性的筛选[J]. 中成药, 2019, 41(1): 55-59. doi: 10. 3969 /j．issn．1001-1528. 2019. 01. 012
9	YU W Y, LI L, WU F, et al. Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4/NF-κB/MLCK pathway[J]. Journal of Ethnopharmacology, 2020, 253: 112641. doi: 10.1016/j.jep.2020.112641
10	邓东沅, 顾立刚, 刘晓婷, 等. 木犀草素体外对H1N1感染A549诱导凋亡的干预作用及机制[J]. 中华中医药杂志, 2017, 32(4): 1524-1527.
11	任开明, 周兆丽, 石文君. 木犀草素对人非小细胞肺癌A549细胞增殖、凋亡、侵袭及迁移能力的影响[J]. 解剖科学进展, 2019, 25(4): 361-363. doi: 10.16695/j.cnki.1006-2947.2019.04.004
12	张雅雯, 邵东燕, 师俊玲, 等. 山奈酚生物功能研究进展[J]. 生命科学, 2017, 29(4): 400-405. doi: 10.13376/j.cbls/2017053
13	HUANG H, LI L F, SHI W M, et al. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro[J]. Evidence-based Complementary and Alternative Medicine, 2016, 2016: 2918796. doi: 10.1155/2016/2918796
14	PATEL K, SINGH G K, PATEL D K. A review on pharmacological and analytical aspects of naringenin[J]. Chinese Journal of Integrative Medicine, 2018, 24(7): 551-560. doi: 10.1007/s11655-014-1960-x
15	马纳, 李亚静, 范吉平. 金合欢素药理研究进展[J]. 中国现代应用药学, 2018, 35(10): 1591-1595. doi: 10.13748/j.cnki.issn1007-7693.2018.10.035
16	ZHI H J, JIN X, ZHU H Y, et al. Exploring the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza a virus induced acute lung injury[J]. Journal of Pharmaceutical and Biomedical Analysis, 2020, 177: 112876. doi: 10.1016/j.jpba.2019.112876
17	WAN Y S, SHANG J, GRAHAM R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus[J].Journal of Virology,2020:31996437. doi: 10.11281 JVI.00127-20
18	刘静,范梦月,孙凯滨,等.基于分子对接柴胡桂枝干姜汤干预初期寒湿郁肺型新型冠状病毒肺炎的活性成分及功效作用机制探讨[J].中草药,2020,51(7):1704-1712. doi: 10.7501/j.issn.0253-2670.2020.07.004
19	姚卫峰,翟园园,林丽丽,等.融合“成分-靶点-共有通路”网络和分子对接技术的清肺口服液抗新型冠状病毒肺炎的活性成分初探[J].南京中医药大学学报,2020,32(2):174-178. doi: 10.14148/j.issn.1672-0482.2020.0174
20	宗阳,丁美林,贾可可,等.基于网络药理学和分子对接法探寻达原饮治疗新型冠状病毒(2019-nCoV)肺炎活性化合物的研究[J].中草药,2020,51(4):836-844. doi: 10.7501/j.issn.0253-2670.2020.04.002
21	邓燕君, 刘博文, 贺桢翔, 等. 基于网络药理学和分子对接法探索藿香正气口服液预防新型冠状病毒肺炎(COVID-19)活性化合物研究[J].中草药, 2020, 51(5): 1113-1122. doi: 10.7501/j.issn.0253-2670.2020.05.004
22	姚运秀, 贺桢翔, 刘晓凤, 等. 基于网络药理学和分子对接技术的抗病毒颗粒治疗新型冠状病毒肺炎(COVID-19)的潜在物质基础研究[J]. 中草药, 2020, 51(6): 1386-1396. doi: 10.7501/j.issn.0253-2670.2020.06.003
23	GUO Y J,PAN W W,LIU S B,et al.ERK/MAPK signalling pathway and tumorigenesis[J].Experimental and Therapeutic Medicine,2020,19(3):1997-2007. doi: 10.38921etm.2020.8454
24	STENNICKE H R, SALVESEN G S. Caspases - controlling intracellular signals by protease zymogen activation[J]. Biochimica et Biophysica Acta, 2000, 1477(1): 299-306. doi: 10.1016/S0167-4838(99)00281-2
25	CHEN C, LIU T S, ZHAO S C, et al. XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma[J]. Experimental and Therapeutic Medicine, 2018, 15(5): 4587-4593. doi: 10.3892/etm.2018.5974
26	李艺敏, 陈健, 何剑全, 等. 巴戟天含药血清对成骨-破骨细胞共育体系原癌基因、核心结合因子1mRNA表达的影响[J]. 中国老年学杂志, 2015, 35(9): 2328-2331. doi: 10. 3969 /j. issn. 1005-9202. 2015. 09. 010.
27	韩莹, 蔡庆宇, 张岩. 泻肺定喘汤对中性粒细胞型哮喘大鼠KLF-2/RelA比例平衡及中性粒细胞凋亡的影响[J]. 中国中医急症, 2019, 28(4): 607-610, 614. DOI：10.3969/j.issn.1004-745X.2019.04.012.
28	ZHOU B X, YANG Z F, FENG Q T, et al. Aurantiamide acetate from Baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza a virus-infected cells[J]. Journal of Ethnopharmacology, 2017, 199: 60-67. doi: 10.1016/j.jep.2017.01.038
29	LIAO X Z, GAO Y, SUN L L, et al. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway[J]. Phytotherapy Research, 2020, 34(5): 1142-1153. doi: 10.1002/ptr.6584
30	SREEHARSHA N. Embelin impact on paraquat-induced lung injury through suppressing oxidative stress, inflammatory cascade, and MAPK/NF-κB signaling pathway[J].Journal of Biochemical and Molecular Toxicology,2020,34(4):e22456. doi: 10.10021 jbt.22456
31	HU T J, SHEN H B, HUANG H B, et al. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling[J]. Anti-Cancer Drugs, 2020, 31(4): 377-384. doi: 10.1097/CAD.0000000000000885
32	TAN Z C, SHI Y Y, YAN Y, et al. Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats[J]. Renal Failure, 2015, 37(4): 727-733. doi: 10.3109/0886022X.2015.1012983
33	TOTURA A L, WHITMORE A, AGNIHOTHRAM S, et al. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection［J］.American Society for Microbiology,2015,6(3):e00638-15. doi: 10.1128/mBio.00638-15
34	林巧卫, 张思, 陆维祺. NOD样受体介导的信号转导通路及其与肿瘤关系的研究进展[J]. 中国癌症杂志, 2019, 29(3): 223-228. doi: 10.19401/j.cnki.1007-3639.2019.03.011

Metrics

Comments

Recommended 0

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0

[1]	GUO Yingjian, YU Jinqian, DONG Hongjing, WANG Chuangchuang, ZHONG Kai, WANG Xiao. Topological analysis reveals mechanism of Panax notoginseng saponin in the treatment of gouty arthritis based on network pharmacology and in vitro experiments [J]. Shandong Science, 2025, 38(5): 40-48.
[2]	SUN Jingtian, LIU Feng, ZHANG Zhe, ZHANG Yufu, MA Xinhui, LI Qingjun, WANG Xiao, DONG Hongjing. Exploring the medication rule of Chrysanthemum morifolium Ramat. and investigating the synergistic pharmacological activity of core combination herbs [J]. Shandong Science, 2025, 38(1): 1-8.
[3]	HAN Huijie, LIU Hui, ZHAO Yongbo, WANG Songpo. A study based on network pharmacology and experimental verification exploring the mechanism of quercetin against colorectal cancer through the p53 signaling pathway [J]. Shandong Science, 2025, 38(1): 32-43.
[4]	FAN Wei, SHEN Chuanlin, ZHANG Xuanming, DU Xingshuo, ZHAN Wen, SUN Chen, JIN Meng, LI Xiaobin, ZHANG Sichen, SUN Botong, HE Qiuxia. Prediction of anti-aging mechanism of Panax quinquefolius L. by network pharmacology and molecular docking [J]. Shandong Science, 2024, 37(6): 42-50.
[5]	YAN Jin, LI Fei, WU Keming, YANG Haobo. The molecular mechanisms by which Xinjia Cistanche Tusi Decoction promotes follicular development through mitophagy [J]. Shandong Science, 2024, 37(5): 25-34.
[6]	LIN Shenghua, XUE Chang, MA honglin, FAN Wei, SHEN Chuanlin, CHEN Jiayu, SUN Botong, DU Xingshuo, ZHAN Wen, LI Xiaobin, ZHANG Shanshan, JIN Meng, HE Qiuxia. Study of the active components and mechanism of action of antithrombotic Xuefuzhuyu oral liquid based on network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(4): 26-33.
[7]	MA Shijing, HE Chunyan, GUAN Tianzhu, YAO Xueshuang, ZHANG Junpeng. Exploration of antihyperlipidemia mechanism of Monopterus albus peptides based on hyperlipidemic zebrafish model and network pharmacology [J]. Shandong Science, 2024, 37(3): 27-38.
[8]	WEI Zekun, YANG Yujie, LIU Shuang, WANG Yan, DONG Hongjing, LIU Chunmei. Reverse mining of Chinese medicine for intervention of liver cancer based on GEO database combined with network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(3): 39-47.
[9]	LIU Kechun, WANG Yongcheng, ZANG Xiaohan, XIA Qing, ZHANG Yun, ZHANG Shanshan, SUN Chen. Advancements in network pharmacology and zebrafish modeling for studying traditional Chinese medicine’s effective substances and mechanisms of action [J]. Shandong Science, 2024, 37(2): 29-35.
[10]	FU Zhaoju, CHENG Guo, LIN Dengmei, LI Jun, ZHANG Nannan. Experimental study and network pharmacological analysis of the anti-inflammatory action mechanism of Mahonia bealei (Fort.) Carr. [J]. Shandong Science, 2024, 37(1): 24-31.
[11]	CHEN Chun, QI Daqing, PAN Jingwen. Clinical significance of stromal cell score in gastric cancer and intervention with Weifuchun capsules [J]. Shandong Science, 2023, 36(6): 38-47.
[12]	MU Nana, LIAO Binbin, LI Zhen, LI Jipin, LI Yihua, WANG Ying, CHEN Xubing. Investigating the mechanism of action of Elephantopus scaber L. in the treatment of ulcerative colitis based on network pharmacology and molecular docking [J]. Shandong Science, 2023, 36(6): 48-55.
[13]	WANG Yifan, ZHANG Zhe, TIAN Caijun. Mechanism of Sanhuang Xiexin decoction in treatment of Alzheimer's disease based on network pharmacology and molecular docking method [J]. Shandong Science, 2023, 36(5): 19-26.
[14]	FU Mengya, AO Huihao, BU Chao, PENG Tangyi, WU Deling, HAN Yanquan, HONG Yan. Forecast analysis of the quality markers of Zingiberis Rhizoma based on fingerprints and network pharmacology [J]. Shandong Science, 2023, 36(4): 35-41.
[15]	YIN Zhipeng, GAO Yunyun, LIU Wenwen, GUO Pengbo, ZHAO Yinghui. Exploring the mechanism of Xiangsha Liujunzi Decoction in treating Helicobacter pylori-associated gastritis based on network pharmacology and molecular docking technology [J]. Shandong Science, 2023, 36(4): 52-60.

Mechanism of Huangqi Liujunzi decoction in treating the recovery stage of COVID-19 based on network pharmacology

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 34

Related Articles 15

Metrics

Comments

Recommended 0